Literature DB >> 1723186

Electroretinogram b-wave implicit time and b/a wave ratio as a function of intensity in central retinal vein occlusion.

M E Breton1, A W Schueller, D P Montzka.   

Abstract

The ability of electroretinogram (ERG) b-wave implicit time and b/a wave ratio to predict iris neovascular response was analyzed as a function of stimulus intensity over a 3.6 log unit intensity range in 39 patients with central retinal vein occlusion (CRVO). Predictive power for CRVO patients was evaluated using ROC area at intensities of 1.23, 1.83, 2.43, and 3.03 effective log quanta/rod, where reliable data for both parameters were obtainable from most patients. The relative predictive power of b-wave implicit time and b/a wave ratio were shown to vary with stimulus intensity. The predictive power of b-wave implicit time, as measured by ROC area, declined to below significance at high intensity (above 1.83 log quanta/rod), while b/a wave ratio performed best at middle intensities (1.83 and 2.43 log quanta/rod) and not as well at high and low intensities. Further analysis of statistical behavior of both ERG parameters was obtained from the t statistic. Insight into the mechanism influencing predictive power of b-wave implicit time was derived from measurements on normal adults and CRVO patients with response data taken at high intensities. These results suggest that an optimal stimulus intensity range can be found for these ERG parameters in the evaluation of CRVO.

Entities:  

Mesh:

Year:  1991        PMID: 1723186     DOI: 10.1016/s0161-6420(91)32057-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  Wide field multifocal and standard full field electroretinographic features of hemi retinal vein occlusion.

Authors:  Fiona Mary Dolan; Stuart Parks; David Keating; Gordon Neale Dutton
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

2.  The flicker electroretinogram interocular amplitude ratio is a strong prognostic indicator of neovascularization in patients with central retinal vein occlusion.

Authors:  Hsi-Kung Kuo; Ming-Tse Kuo; Yung-Jen Chen; Pei-Chang Wu; Chih-Hsin Chen; Yi-Hao Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-08       Impact factor: 3.117

3.  Rod and cone a-waves in central retinal vein occlusion.

Authors:  Naoyuki Tanimoto; Tomoaki Usui; Mikio Ichibe; Mineo Takagi; Keiko Suzuki; Shigeru Hasegawa; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

4.  Photopic 30 Hz flicker ERG as a predictor for rubeosis in central retinal vein occlusion.

Authors:  J Larsson; S Andréasson
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

5.  Morphological and electrophysiological outcome in prospective intravitreal bevacizumab treatment of macular edema secondary to central retinal vein occlusion.

Authors:  Ivana Gardašević Topčić; Maja Šuštar; Jelka Brecelj; Marko Hawlina; Polona Jaki Mekjavić
Journal:  Doc Ophthalmol       Date:  2014-06-07       Impact factor: 2.379

6.  Electroretinograms and level of aqueous vascular endothelial growth factor in eyes with hemicentral retinal vein occlusion or branch retinal vein occlusion.

Authors:  Shunsuke Yasuda; Shu Kachi; Shinji Ueno; Hiroaki Ushida; Chang-Hua Piao; Mineo Kondo; Hiroko Terasaki
Journal:  Jpn J Ophthalmol       Date:  2014-03-26       Impact factor: 2.447

7.  Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype.

Authors:  Timm Schubert; Corinna Gleiser; Peter Heiduschka; Christoph Franz; Kerstin Nagel-Wolfrum; Ayse Sahaboglu; Nicole Weisschuh; Gordon Eske; Karin Rohbock; Norman Rieger; François Paquet-Durand; Bernd Wissinger; Uwe Wolfrum; Bernhard Hirt; Wibke Singer; Lukas Rüttiger; Ulrike Zimmermann; Marlies Knipper
Journal:  Cell Mol Life Sci       Date:  2015-05-06       Impact factor: 9.261

8.  Prevalence of electronegative electroretinograms in a healthy adult cohort.

Authors:  Xiaofan Jiang; Taha Bhatti; Ambreen Tariq; Katie M Williams; Isabelle Chow; Talib Dar; Andrew R Webster; Pirro G Hysi; Christopher J Hammond; Omar A Mahroo
Journal:  BMJ Open Ophthalmol       Date:  2021-07-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.